Cassian Yee

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

62h-index17.7kcitations341works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(147), Immunotherapy and Immune Responses(127), Immune Cell Function and Interaction(89), Cancer Immunotherapy and Biomarkers(79), T-cell and B-cell Immunology(44)

Publications340 total

The E2F1-HMGCR axis promotes ferroptosis resistance in immune refractory tumor cells
Nature Communications·2025· 1 citedOpen Access
1272 EpCAM signaling promotes immunosuppressive tumor microenvironment and a novel therapeutic antibody enhances anti-tumor immunity
Regular and Young Investigator Award Abstracts·2025Open Access
Mutation of conserved MHC class I cytoplasmic tyrosine affects CD8+ T cell priming, effector function, and memory response
Frontiers in Immunology·2025Open Access
AI/ML-empowered approaches for predicting T Cell-mediated immunity and beyond
Frontiers in Immunology·2025· 2 citedOpen Access
Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.
Journal of Clinical Oncology·2025
Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity
Immunity·2025· 8 citedOpen Access
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
Nature·2025· 40 cited
BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism
Cell Death Discovery·2025· 5 citedOpen Access
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
JCI Insight·2025· 11 citedOpen Access
CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancers
2025· 1 citedOpen Access
Urine proteomics defines an immune checkpoint-associated nephritis signature
Journal for ImmunoTherapy of Cancer·2025· 8 citedOpen Access
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism
2024Open Access
Contributors
Elsevier eBooks·2024Open Access
Modulating T cell metabolism to improve T cell therapy
Elsevier eBooks·2024
Developing Novel Cellular Therapies for Cutaneous T Cell Lymphoma (CTCL): Combining Immunopeptidomics and Endogenous T Cell (ETC) Therapy Platforms to Identify and Target Shared CTCL-Associated Antigens
Blood·2024Open Access
387 Identification of novel T cell receptor (TCR) target to brachyury for the development of T cell-based immunotherapy of chordoma and other solid tumors
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
358 T cell receptor engineering targeting EGFR-mutant non-small cell lung cancer
Regular and Young Investigator Award Abstracts·2024Open Access
872 Quaking modulates anti-tumor immunity by regulating antigen processing and presentation in dendritic cells
Regular and Young Investigator Award Abstracts·2024Open Access
Tumor-resident Lactobacillus iners confers chemoradiation resistance through lactate-induced metabolic rewiring
immuneACCESS·2024
Association of Novel Urine Biomarkers with Immune Checkpoint Inhibitor Nephrotoxicity
Journal of the American Society of Nephrology·2024· 1 cited
page 1 of 17Next →

Frequent Co-authors

Philip D. Greenberg(11), Kyung‐Mi Lee(7), Stanley R. Riddell(6), John A. Thompson(5), Aude G. Chapuis(5), Jianhong Cao(4), Anirban Maitra(4), David M. Koelle(4), Noha Abdel‐Wahab(4), Michael A. Davies(4), Adi Diab(4), Shailender Bhatia(4), Ivy Lai(4), Erik Farrar(4), John A. Thompson(3), Peter P. Lee(3), Mark M. Davis(3), Rebecca M. Rodmyre(3), Jennifer A. Wargo(3), Daniel H. Johnson(3)